LOINC_NUM
stringlengths 3
8
| COMPONENT
stringlengths 2
246
| PROPERTY
stringlengths 1
29
| TIME_ASPCT
stringlengths 1
15
| SYSTEM
stringlengths 1
106
| SCALE_TYP
stringclasses 10
values | METHOD_TYP
stringlengths 1
57
⌀ | CLASS
stringlengths 2
24
| CLASSTYPE
int64 1
4
| LONG_COMMON_NAME
stringlengths 3
254
| SHORTNAME
stringlengths 2
51
⌀ | EXTERNAL_COPYRIGHT_NOTICE
stringlengths 39
2.6k
⌀ | STATUS
stringclasses 4
values | VersionFirstReleased
stringlengths 1
7
| VersionLastChanged
stringlengths 1
5
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
96990-7
|
Vaccine administration location
|
Type
|
Pt
|
^Event
|
Nom
| null |
VACCIN
| 2 |
Vaccine administration location
|
Vaccine administration loc
| null |
ACTIVE
|
2.70
|
2.7
|
96991-5
|
Vaccine administration county
|
Loc
|
Pt
|
^Event
|
Nom
| null |
VACCIN
| 2 |
Vaccine administration county [Location]
|
Vaccine administration county
| null |
ACTIVE
|
2.70
|
2.7
|
96992-3
|
Vaccine administration state
|
Loc
|
Pt
|
^Event
|
Nom
| null |
VACCIN
| 2 |
State where vaccine was administered
|
Vaccine administration state
| null |
ACTIVE
|
2.70
|
2.7
|
96993-1
|
Federal agency code
|
ID
|
Pt
|
Agency
|
Nom
| null |
ADMIN
| 2 |
Federal agency code
|
Federal agency code
| null |
ACTIVE
|
2.70
|
2.7
|
96994-9
|
Vaccine doses distributed
|
Num
|
Pt
|
^Event
|
Qn
| null |
VACCIN
| 2 |
Vaccine doses distributed [#]
|
Vaccine doses distributed
| null |
ACTIVE
|
2.70
|
2.7
|
96995-6
|
Vaccine doses distributed/100,000 population
|
NRto
|
Pt
|
^Event
|
Qn
| null |
VACCIN
| 2 |
Total vaccine doses distributed per 100,000 population
|
Vac doses dist per 100,000
| null |
ACTIVE
|
2.70
|
2.7
|
96996-4
|
People who have received first dose of vaccine
|
Num
|
Pt
|
^Population
|
Qn
| null |
VACCIN
| 2 |
People who have received first dose of vaccine [#] Population
|
People rcvd first dose of vaccine Pop
| null |
ACTIVE
|
2.70
|
2.7
|
96997-2
|
People who have received first dose of vaccine/100,000 population
|
NFr
|
Pt
|
^Population
|
Qn
| null |
VACCIN
| 2 |
Count of people who initiated vaccination per 100,000 population
|
Rcvd first dose of vaccine/100,00 pop
| null |
ACTIVE
|
2.70
|
2.7
|
96998-0
|
People who are fully vaccinated
|
Num
|
Pt
|
^Population
|
Qn
| null |
VACCIN
| 2 |
Count of people who are fully vaccinated in Population
|
People who fully vaccinated Pop
| null |
ACTIVE
|
2.70
|
2.7
|
96999-8
|
People who are fully vaccinated/100,000 population
|
NFr
|
Pt
|
^Population
|
Qn
| null |
VACCIN
| 2 |
Count of people who are fully vaccinated per 100,000 population
|
People who fully vaccinated/100,000 pop
| null |
ACTIVE
|
2.70
|
2.7
|
97000-4
|
Vaccine doses distributed for use in long term care facilities
|
Num
|
Pt
|
^Event
|
Qn
| null |
VACCIN
| 2 |
Vaccine doses distributed for use in long term care facilities [#]
|
Vaccine doses distributed to LTCFs
| null |
ACTIVE
|
2.70
|
2.7
|
97001-2
|
Vaccine administration tier
|
Type
|
Pt
|
^Event
|
Nom
| null |
VACCIN
| 2 |
Vaccine administration tier
|
Vaccine administration tier
| null |
ACTIVE
|
2.70
|
2.7
|
97002-0
|
People in long-term care facilities who have received first dose of vaccine
|
Num
|
Pt
|
^Population
|
Qn
| null |
VACCIN
| 2 |
Number of people in long-term care facilities who have received first dose of vaccine
|
# People in LTCFs rcvd 1st dose vaccine
| null |
ACTIVE
|
2.70
|
2.7
|
97003-8
|
People in long-term care facilities who are fully vaccinated
|
Num
|
Pt
|
^Population
|
Qn
| null |
VACCIN
| 2 |
Number of people in long-term care facilities who are fully vaccinated
|
# People in LTCFs fully vaccinated
| null |
ACTIVE
|
2.70
|
2.7
|
97004-6
|
Insulin type
|
Prid
|
Pt
|
Ser/Plas
|
Nom
|
LC/MS/MS
|
CHEM
| 1 |
Insulin type [Identifier] in Serum or Plasma by LC/MS/MS
|
Insulin Type SerPl LC/MS/MS
| null |
ACTIVE
|
2.70
|
2.7
|
97005-3
|
Maximum clot strength amplitude.kaolin+tissue factor induced
|
Len
|
Pt
|
Bld
|
Qn
|
Thromboelastography.resonance
|
COAG
| 1 |
Maximum amplitude kaolin+tissue factor induced [Length] in Blood by Resonance TEG
|
MA kaolin+TF Bld Res TEG
| null |
ACTIVE
|
2.70
|
2.7
|
9700-6
|
Procaine
|
MCnc
|
Pt
|
Ser/Plas
|
Qn
| null |
DRUG/TOX
| 1 |
Procaine [Mass/volume] in Serum or Plasma
|
Procaine SerPl-mCnc
| null |
ACTIVE
|
1.0i
|
2.73
|
97006-1
|
Maximum clot strength amplitude.kaolin+tissue factor induced
|
Len
|
Pt
|
Bld
|
Qn
| null |
COAG
| 1 |
Maximum amplitude kaolin+tissue factor induced [Length] in Blood
|
MA kaolin+TF Bld
| null |
ACTIVE
|
2.70
|
2.7
|
97007-9
|
Clot initiation.kaolin induced^post heparin neutralization
|
Time
|
Pt
|
Bld
|
Qn
|
Thromboelastography.resonance
|
COAG
| 1 |
Clot initiation.kaolin induced [Time] in Blood by Resonance TEG --post heparin neutralization
|
Clot init kao ind p hep neut Bld Res TEG
| null |
ACTIVE
|
2.70
|
2.7
|
97008-7
|
Clot initiation.kaolin+tissue factor induced
|
Time
|
Pt
|
Bld
|
Qn
| null |
COAG
| 1 |
Clot initiation.kaolin+tissue factor induced [Time] in Blood
|
Clot init kaolin+TF ind Bld
| null |
ACTIVE
|
2.70
|
2.7
|
97009-5
|
Activated clotting time.kaolin+tissue factor induced
|
Time
|
Pt
|
Bld
|
Qn
|
Calculated
|
COAG
| 1 |
Activated clotting time.kaolin+tissue factor induced of Blood by calculation
|
ACT Kaolin+TF Ind Bld Calc
| null |
ACTIVE
|
2.70
|
2.7
|
97010-3
|
Clot formation.kaolin+tissue factor induced
|
Time
|
Pt
|
Bld
|
Qn
| null |
COAG
| 1 |
Clot formation kaolin+tissue factor induced [Time] in Blood
|
CFT kaolin+TF ind Bld
| null |
ACTIVE
|
2.70
|
2.7
|
97011-1
|
Clot angle.kaolin+tissue factor induced
|
Angle
|
Pt
|
Bld
|
Qn
| null |
COAG
| 1 |
Clot angle kaolin+tissue factor induced in Blood
|
Clot angle kaolin+TF ind Bld
| null |
ACTIVE
|
2.70
|
2.7
|
97012-9
|
Reduction in clot strength.kaolin+tissue factor induced^30M post maximum clot amplitude
|
LenFr
|
Pt
|
Bld
|
Qn
| null |
COAG
| 1 |
Reduction in kaolin+tissue factor induced clot strength [Length fraction] in Blood --30 minutes post maximum clot amplitude
|
Lysis kao+TF ind clot 30M p MA LenFr Bld
| null |
ACTIVE
|
2.70
|
2.7
|
97013-7
|
Reduction in clot strength.kaolin induced^30M post maximum clot amplitude
|
LenFr
|
Pt
|
Bld
|
Qn
|
Thromboelastography.resonance
|
COAG
| 1 |
Reduction in kaolin induced clot strength [Length fraction] in Blood by Resonance TEG --30 minutes post maximum clot amplitude
|
Lys kao ind clt 30M p MA LenFr Bl ResTEG
| null |
ACTIVE
|
2.70
|
2.7
|
9701-4
|
sulfiSOXAZOLE
|
MCnc
|
Pt
|
Ser/Plas
|
Qn
| null |
DRUG/TOX
| 1 |
sulfiSOXAZOLE [Mass/volume] in Serum or Plasma
|
Sulfisoxaz SerPl-mCnc
| null |
ACTIVE
|
1.0i
|
2.7
|
97014-5
|
Maximum clot strength amplitude.tissue factor induced+platelet glycoprotein IIb-IIIa receptor inhibited
|
Len
|
Pt
|
Bld
|
Qn
|
Thromboelastography.resonance
|
COAG
| 1 |
Maximum amplitude tissue factor induced+platelet glycoprotein IIb-IIIa receptor inhibited [Length] in Blood by Resonance TEG
|
MA TF ind+IIb-IIIa inh Bld Res TEG
| null |
ACTIVE
|
2.70
|
2.7
|
97015-2
|
Maximum clot strength amplitude.tissue factor induced+platelet glycoprotein IIb-IIIa receptor inhibited
|
Len
|
Pt
|
Bld
|
Qn
| null |
COAG
| 1 |
Maximum amplitude tissue factor induced+platelet glycoprotein IIb-IIIa receptor inhibited [Length] in Blood
|
MA TF ind+IIb-IIIa inh Bld
| null |
ACTIVE
|
2.70
|
2.7
|
97016-0
|
Fibrinogen
|
MCnc
|
Pt
|
Bld
|
Qn
|
Calculated
|
COAG
| 1 |
Fibrinogen [Mass/volume] in Blood by calculation
|
Fibrinogen Bld Calc-mCnc
| null |
ACTIVE
|
2.70
|
2.7
|
97017-8
|
Maximum clot strength amplitude.kaolin induced^after addition of heparinase
|
Len
|
Pt
|
Bld
|
Qn
| null |
COAG
| 1 |
Maximum amplitude kaolin induced [Length] in Blood --after addition of heparinase
|
MA kaolin P Hpase Bld
| null |
ACTIVE
|
2.70
|
2.7
|
97018-6
|
Maximum clot strength amplitude.activator F induced
|
Len
|
Pt
|
Bld
|
Qn
| null |
COAG
| 1 |
Maximum amplitude activator F induced [Length] in Blood
|
MA ActF Bld
| null |
ACTIVE
|
2.70
|
2.7
|
97019-4
|
Maximum clot strength amplitude.adenosine diphosphate induced
|
Len
|
Pt
|
Bld
|
Qn
| null |
COAG
| 1 |
Maximum amplitude ADP induced [Length] in Blood
|
MA ADP Bld
| null |
ACTIVE
|
2.70
|
2.7
|
97020-2
|
Maximum clot strength amplitude.arachidonate induced
|
Len
|
Pt
|
Bld
|
Qn
| null |
COAG
| 1 |
Maximum amplitude arachidonate induced [Length] in Blood
|
MA AA Bld
| null |
ACTIVE
|
2.70
|
2.7
|
97021-0
|
Reduction in clot strength.kaolin induced^30M post maximum clot amplitude
|
LenFr
|
Pt
|
Bld
|
Qn
| null |
COAG
| 1 |
Reduction in kaolin induced clot strength [Length fraction] in Blood --30 minutes post maximum clot amplitude
|
Lys of kao ind clot 30M p MA LenFr Bld
| null |
ACTIVE
|
2.70
|
2.7
|
9702-2
|
Terbutaline
|
MCnc
|
Pt
|
Ser/Plas
|
Qn
| null |
DRUG/TOX
| 1 |
Terbutaline [Mass/volume] in Serum or Plasma
|
Terbutaline SerPl-mCnc
| null |
ACTIVE
|
1.0i
|
2.7
|
97022-8
|
Clot strength.arachidonate inhibited
|
LenFr
|
Pt
|
Bld
|
Qn
|
Calculated
|
COAG
| 1 |
Clot strength arachidonate inhibited [Length fraction] in Blood by calculation
|
Clot strength AA inhib LenFr Bld Calc
| null |
ACTIVE
|
2.70
|
2.7
|
97023-6
|
Accountable health communities health-related social needs supplemental questions
|
-
|
Pt
|
^Patient
|
-
| null |
PANEL.SURVEY.GNHLTH
| 4 |
Accountable health communities (AHC) health-related social needs (HRSN) supplemental questions
| null | null |
ACTIVE
|
2.70
|
2.7
|
97024-4
|
aPTT mixing study panel
|
-
|
Pt
|
PPP
|
-
| null |
PANEL.COAG
| 1 |
aPTT mixing study panel - Platelet poor plasma
|
aPTT Mix Pnl PPP
| null |
ACTIVE
|
2.70
|
2.7
|
97025-1
|
BRAF gene.p.Val600 mutations
|
Prid
|
Pt
|
Tiss
|
Nom
|
Molgen
|
MOLPATH.MUT
| 1 |
BRAF gene V600 mutations [Identifier] in Tissue by Molecular genetics method Nominal
|
BRAF p.V600 mutations Tiss
| null |
ACTIVE
|
2.70
|
2.7
|
97026-9
|
Phosphatidylserine-prothrombin complex Ab.IgG & IgM panel
|
-
|
Pt
|
Ser/Plas
|
-
| null |
PANEL.COAG
| 1 |
Phosphatidylserine-prothrombin complex IgG and IgM panel - Serum or Plasma
|
PS-prothrom cmplx IgG IgM Pnl SerPl
| null |
ACTIVE
|
2.70
|
2.7
|
97027-7
|
Speaks a language other than English at home
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.GNHLTH
| 4 |
Speaks a language other than English at home
| null | null |
ACTIVE
|
2.70
|
2.7
|
97029-3
|
Spine Tango surgery follow-up 2017
|
-
|
Pt
|
^Patient
|
-
|
Spine Tango
|
PANEL.SURG
| 2 |
Spine Tango surgery follow-up 2017 Spine Tango
|
Spine Tango surgery f/u 2017 Spine Tango
|
Copyright © 2020 EUROSPINE. All rights reserved.
|
ACTIVE
|
2.70
|
2.7
|
9703-0
|
Trihexyphenidyl
|
MCnc
|
Pt
|
Ser/Plas
|
Qn
| null |
DRUG/TOX
| 1 |
Trihexyphenidyl [Mass/volume] in Serum or Plasma
|
Trihexyphenidyl SerPl-mCnc
| null |
ACTIVE
|
1.0i
|
2.7
|
97030-1
|
Level of spine intervention
|
Find
|
Pt
|
^Patient
|
Nom
| null |
SURG
| 2 |
Level of spine intervention
|
Level of spine intervention
| null |
ACTIVE
|
2.70
|
2.7
|
97031-9
|
Follow-up panel
|
-
|
Pt
|
^Patient
|
-
|
Spine Tango
|
PANEL.SURG
| 2 |
Follow-up panel Spine Tango
|
Spine Tango
|
Copyright © 2020 EUROSPINE. All rights reserved.
|
ACTIVE
|
2.70
|
2.7
|
97032-7
|
Postoperative follow-up interval
|
Find
|
Pt
|
^Patient
|
Nom
| null |
H&P.HX
| 2 |
Postoperative follow-up interval
|
Postop follow-up interval
| null |
ACTIVE
|
2.70
|
2.7
|
97033-5
|
Postoperative work status
|
Find
|
Pt
|
^Patient
|
Nom
| null |
SURVEY.GNHLTH
| 4 |
Postoperative work status
| null | null |
ACTIVE
|
2.70
|
2.7
|
97034-3
|
Postoperative therapeutic goals or measures that were achieved
|
Find
|
Pt
|
^Patient
|
Nom
| null |
SURG
| 2 |
Postoperative therapeutic goals or measures that were achieved
|
Postop ther goals achieved
| null |
ACTIVE
|
2.70
|
2.7
|
97035-0
|
Postoperative therapeutic goals or measures that were partially achieved
|
Find
|
Pt
|
^Patient
|
Nom
| null |
SURG
| 2 |
Postoperative therapeutic goals or measures that were partially achieved
|
Postop ther goals partially achieved
| null |
ACTIVE
|
2.70
|
2.7
|
97036-8
|
Postoperative therapeutic goals or measures that were not achieved
|
Find
|
Pt
|
^Patient
|
Nom
| null |
SURG
| 2 |
Postoperative therapeutic goals or measures that were not achieved
|
Postop ther goals not achieved
| null |
ACTIVE
|
2.70
|
2.7
|
97037-6
|
Medication for spinal surgery or pathology
|
Find
|
Pt
|
^Patient
|
Nom
| null |
SURG
| 2 |
Medication for spinal surgery or pathology
|
Meds spinal surgery/pathology
| null |
ACTIVE
|
2.70
|
2.7
|
97038-4
|
Postoperative rehabilitation
|
Find
|
Pt
|
^Patient
|
Nom
| null |
SURG
| 2 |
Postoperative rehabilitation
|
Postop rehab
| null |
ACTIVE
|
2.70
|
2.7
|
97039-2
|
Overall outcome of spine surgery
|
Find
|
Pt
|
^Patient
|
Nom
| null |
SURG
| 2 |
Overall outcome of spine surgery
|
Overall outcome of spine surgery
| null |
ACTIVE
|
2.70
|
2.7
|
970-4
|
Weak D Ag
|
PrThr
|
Pt
|
RBC^BPU
|
Ord
| null |
BLDBK
| 1 |
Weak D Ag [Presence] on Red Blood Cells from Blood product unit
|
Weak D Ag RBC BPU Ql
| null |
ACTIVE
|
1.0
|
2.7
|
97040-0
|
Postoperative follow-up care decision
|
Find
|
Pt
|
^Patient
|
Nom
| null |
SURG
| 2 |
Postoperative follow-up care decision
|
Postop follow-up care decision
| null |
ACTIVE
|
2.70
|
2.7
|
97041-8
|
Comments regarding postoperative follow-up
|
Find
|
Pt
|
^Patient
|
Nom
| null |
SURG
| 2 |
Comments regarding postoperative follow-up
|
Comments re: postop follow-up
| null |
ACTIVE
|
2.70
|
2.7
|
97042-6
|
Complications panel
|
-
|
Pt
|
^Patient
|
-
|
Spine Tango
|
PANEL.SURG
| 2 |
Complications panel Spine Tango
|
Complications pnl Spine Tango
|
Copyright © 2020 EUROSPINE. All rights reserved.
|
ACTIVE
|
2.70
|
2.7
|
97043-4
|
Postoperative complication occurred
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURG
| 2 |
Postoperative complication occurred
|
Postop comp occurred
| null |
ACTIVE
|
2.70
|
2.7
|
97044-2
|
Postoperative complication timing
|
Find
|
Pt
|
^Patient
|
Nom
| null |
SURG
| 2 |
Postoperative complication timing
|
Postop complication timing
| null |
ACTIVE
|
2.70
|
2.7
|
97045-9
|
Postoperative complication type
|
Find
|
Pt
|
^Patient
|
Nom
| null |
SURG
| 2 |
Postoperative complication type
|
Postop complication type
| null |
ACTIVE
|
2.70
|
2.7
|
97046-7
|
Postoperative complication treatment needed
|
Find
|
Pt
|
^Patient
|
Nom
| null |
SURG
| 2 |
Postoperative complication treatment needed
|
Postop complication treatment
| null |
ACTIVE
|
2.70
|
2.7
|
97047-5
|
Postoperative complication effect on recovery
|
Find
|
Pt
|
^Patient
|
Nom
| null |
SURG
| 2 |
Postoperative complication effect on recovery
|
Postop comp effect on recvry
| null |
ACTIVE
|
2.70
|
2.7
|
9704-8
|
Spermatozoa
|
Morph
|
Pt
|
Semen
|
Nom
| null |
FERT
| 1 |
Spermatozoa [Morphology] in Semen
|
Sperm Smn
| null |
ACTIVE
|
1.0i
|
2.73
|
97048-3
|
Comments regarding postoperative complications
|
Find
|
Pt
|
^Patient
|
Nom
| null |
SURG
| 2 |
Comments regarding postoperative complications
|
Comments re: postop complications
| null |
ACTIVE
|
2.70
|
2.7
|
97049-1
|
p53 Ab
|
MCnc
|
Pt
|
Ser/Plas
|
Qn
|
IA
|
SERO
| 1 |
p53 Ab [Mass/volume] in Serum or Plasma by Immunoassay
|
p53 Ab SerPl IA-mCnc
| null |
ACTIVE
|
2.70
|
2.7
|
97050-9
|
Acinetobacter calcoaceticus-baumannii complex DNA
|
PrThr
|
Pt
|
Bld.pos growth
|
Ord
|
Non-probe.amp.tar
|
MICRO
| 1 |
Acinetobacter calcoaceticus-baumannii complex DNA [Presence] by NAA with non-probe detection in Positive blood culture
|
ACB complex DNA Bld Pos Ql NAA+non-probe
| null |
ACTIVE
|
2.70
|
2.7
|
97051-7
|
Interferon.beta
|
MCnc
|
Pt
|
Ser/Plas
|
Qn
| null |
CHEM
| 1 |
Interferon beta [Mass/volume] in Serum or Plasma
|
IFN-B SerPl-mCnc
| null |
ACTIVE
|
2.70
|
2.7
|
97052-5
|
Chemokine (C-C motif) ligand 2
|
MCnc
|
Pt
|
Ser/Plas
|
Qn
| null |
CHEM
| 1 |
Chemokine (C-C motif) ligand 2 [Mass/volume] in Serum or Plasma
|
CCL2 SerPl-mCnc
| null |
ACTIVE
|
2.70
|
2.7
|
97053-3
|
Macrophage inflammatory protein 1.alpha
|
MCnc
|
Pt
|
Ser/Plas
|
Qn
| null |
CHEM
| 1 |
Macrophage inflammatory protein 1 alpha [Mass/volume] in Serum or Plasma
|
MIP-1 alpha SerPl-mCnc
| null |
ACTIVE
|
2.70
|
2.71
|
97054-1
|
Granulocyte macrophage colony stimulating factor
|
MCnc
|
Pt
|
Ser/Plas
|
Qn
| null |
CHEM
| 1 |
Granulocyte macrophage colony stimulating factor [Mass/volume] in Serum or Plasma
|
GM-CSF SerPl-mCnc
| null |
ACTIVE
|
2.70
|
2.71
|
9705-5
|
Coccidioides immitis Ab.IgA
|
ACnc
|
Pt
|
Ser
|
Qn
| null |
MICRO
| 1 |
Coccidioides immitis IgA Ab [Units/volume] in Serum
|
C immitis IgA Ser-aCnc
| null |
ACTIVE
|
1.0i
|
2.73
|
97055-8
|
Finnish diabetes risk score panel
|
-
|
Pt
|
^Patient
|
-
|
FINDRISC
|
PANEL.CLIN.RISK
| 2 |
Finnish diabetes risk score panel FINDRISC
|
FINDRISC pnl FINDRISC
| null |
ACTIVE
|
2.70
|
2.7
|
97057-4
|
BMI score for risk calculation
|
Score
|
Pt
|
^Patient
|
Ord
| null |
H&P.HX
| 2 |
BMI score for risk calculation
|
BMI score for risk calc
| null |
ACTIVE
|
2.70
|
2.7
|
97058-2
|
Waist circumference score for risk calculation
|
Score
|
Pt
|
^Patient
|
Ord
| null |
H&P.PX
| 2 |
Waist circumference score for risk calculation
|
Waist circ score for risk calc
| null |
ACTIVE
|
2.70
|
2.7
|
97059-0
|
Physical activity at least 30M per D
|
Find
|
Pt
|
^Patient
|
Ord
| null |
H&P.HX
| 2 |
Physical activity at least 30 minutes per day
|
Physical activity min 30 M/day
| null |
ACTIVE
|
2.70
|
2.7
|
97060-8
|
Vegetable &or fruit frequency
|
NRat
|
Pt
|
^Patient
|
Ord
| null |
H&P.HX
| 2 |
Vegetable AndOr fruit frequency
|
Vegetable AndOr fruit frequency
| null |
ACTIVE
|
2.70
|
2.7
|
97062-4
|
High blood glucose
|
Hx
|
Pt
|
^Patient
|
Ord
| null |
H&P.HX
| 2 |
History of High blood glucose
|
Hx of High blood glucose
| null |
ACTIVE
|
2.70
|
2.7
|
9706-3
|
Coxiella burnetii phase 1 Ab.IgA
|
Titr
|
Pt
|
Ser
|
Qn
| null |
MICRO
| 1 |
Coxiella burnetii phase 1 IgA Ab [Titer] in Serum
|
C burnet Ph1 IgA Titr Ser
| null |
ACTIVE
|
1.0i
|
2.73
|
97063-2
|
Diabetes
|
Hx
|
Pt
|
^Family member
|
Ord
| null |
H&P.HX
| 2 |
Family history of Diabetes
|
Family hx of Diabetes
| null |
ACTIVE
|
2.70
|
2.7
|
97064-0
|
Total risk score
|
Score
|
Pt
|
^Patient
|
Qn
|
FINDRISC
|
CLIN.RISK
| 2 |
Total risk score FINDRISC
|
Total risk score FINDRISC
| null |
ACTIVE
|
2.70
|
2.7
|
97065-7
|
Medical history for preventive vaccination against COVID-19 (Coronavirus Disease 2019) - with mRNA vaccine
|
-
|
Pt
|
^Patient
|
-
| null |
PANEL.VACCIN
| 2 |
Medical history for preventive vaccination against COVID-19 (Coronavirus Disease 2019) - with mRNA vaccine
|
Hx for COVID -19 vaccine
| null |
ACTIVE
|
2.70
|
2.7
|
97066-5
|
Acute illness with fever
|
Find
|
Pt
|
^Patient
|
Ord
| null |
H&P.HX
| 2 |
Acute illness with fever
|
Acute ill w/fever
| null |
ACTIVE
|
2.70
|
2.7
|
97067-3
|
Allergic reaction to first COVID-19 vaccine dose
|
Find
|
Pt
|
^Patient
|
Ord
| null |
VACCIN
| 2 |
Allergic reaction to first COVID-19 vaccine dose
|
Aller react 1st COVID-19 dose
| null |
ACTIVE
|
2.70
|
2.7
|
97068-1
|
Chronic diseases &or immunodeficiency
|
Hx
|
Pt
|
^Patient
|
Ord
| null |
H&P.HX
| 2 |
History of Chronic diseases AndOr immunodeficiency
|
Hx chronic diseases/immunodeficiency
| null |
ACTIVE
|
2.70
|
2.7
|
97069-9
|
Coagulation disorder &or blood-thinning medication use
|
Hx
|
Pt
|
^Patient
|
Ord
| null |
H&P.HX
| 2 |
History of Coagulation disorder AndOr blood-thinning medication use
|
Hx coag disorder &/or bld-thin med
| null |
ACTIVE
|
2.70
|
2.7
|
97070-7
|
Adverse event following prior vaccination
|
Find
|
Pt
|
^Patient
|
Ord
| null |
VACCIN
| 2 |
Adverse event following prior vaccination
|
AE p vaccine
| null |
ACTIVE
|
2.70
|
2.7
|
9707-1
|
Coxiella burnetii phase 2 Ab.IgA
|
Titr
|
Pt
|
Ser
|
Qn
| null |
MICRO
| 1 |
Coxiella burnetii phase 2 IgA Ab [Titer] in Serum
|
C burnet Ph2 IgA Titr Ser
| null |
ACTIVE
|
1.0i
|
2.73
|
97071-5
|
Pregnant or nursing
|
Find
|
Pt
|
^Patient
|
Ord
| null |
H&P.HX
| 2 |
Pregnant or nursing
|
Pregnant/Nursing
| null |
ACTIVE
|
2.70
|
2.7
|
97072-3
|
Vaccinated in last 14 D
|
Find
|
14D
|
^Patient
|
Ord
| null |
VACCIN
| 2 |
Vaccinated in last 14 days
|
Vacc last 14 D
| null |
ACTIVE
|
2.70
|
2.7
|
97073-1
|
Received COVID-19 vaccine
|
Find
|
Pt
|
^Patient
|
Ord
| null |
VACCIN
| 2 |
Received COVID-19 vaccine
|
Rcvd COVID-19 vaccine
| null |
ACTIVE
|
2.70
|
2.7
|
97074-9
|
Mean score
|
Score
|
Pt
|
^Patient
|
Qn
|
CRBS
|
SURVEY.COVID
| 4 |
Mean score [CRBS]
| null |
Copyright 2020 Fisher, Celia B. & Yip, Tiffany - Fordham University Center for Ethics Education. Used with permission.
|
ACTIVE
|
2.70
|
2.71
|
97075-6
|
Total score
|
Score
|
Pt
|
^Patient
|
Qn
|
CAS
|
SURVEY.COVID
| 4 |
Total score [CAS]
| null | null |
ACTIVE
|
2.70
|
2.71
|
97076-4
|
Common news sources
|
Type
|
Pt
|
^Patient
|
Nom
| null |
SURVEY.COVID
| 4 |
Common news sources
| null | null |
ACTIVE
|
2.70
|
2.71
|
97077-2
|
Time spent per day getting information about COVID-19 &or its impact
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
Time spent per day getting information about COVID-19 and/or its impact
| null | null |
ACTIVE
|
2.70
|
2.71
|
97078-0
|
Effect of friends, family or neighbors as source of information on mental health
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
Effect of friends, family or neighbors as source of information on mental health
| null | null |
ACTIVE
|
2.70
|
2.71
|
97079-8
|
Effect of local government officials as source of information on mental health
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
Effect of local government officials as source of information on mental health
| null | null |
ACTIVE
|
2.70
|
2.71
|
97080-6
|
Effect of national government officials as source of information on mental health
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
Effect of national government officials as source of information on mental health
| null | null |
ACTIVE
|
2.70
|
2.71
|
97081-4
|
Effect of national and international health officials as source of information on mental health
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
Effect of national and international health officials as source of information on mental health
| null | null |
ACTIVE
|
2.70
|
2.71
|
97082-2
|
Effect of print or online news as source of information on mental health
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
Effect of print or online news as source of information on mental health
| null | null |
ACTIVE
|
2.70
|
2.71
|
97083-0
|
Effect of radio or podcast as source of information on mental health
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.COVID
| 4 |
Effect of radio or podcast as source of information on mental health
| null | null |
ACTIVE
|
2.70
|
2.71
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.